In 2023, the myotonic dystrophy treatment market is projected to be worth USD 874.39 million. The global demand for myotonic dystrophy treatment is anticipated to increase at a CAGR of 12.3% between ...

In 2020, Dr. Christopher Pearson, Senior Scientist in the Genetics & Genome Biology program at SickKids, ... Khan M, Ciesiołka A, et al. Autism-related traits in myotonic dystrophy type 1 model mice ...

Posters presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference highlight the complex care needs and physical activity barriers for individuals with myotonic dystrophy.

Emerging Myotonic Dystrophy therapies in the different phases of clinical trials are- DM1 program, ENZ-001, JUV 161, DYNE-101, AOC 1001, Pitolisant, Tideglusib, Mexiletine, AMO-02, DYNE-101, ENTR ...

Becker Muscular Dystrophy (BMD) is a genetic disorder first described by Peter Emil Becker in the 1950s. It is a milder variant of Duchenne Muscular Dystrophy (DMD), caused by mutations in the ...

"Dune"-inspired Arrakis Therapeutics has tested its spice—an RNA-targeting small molecule—in a mouse model of myotonic dystrophy type 1 (DM1), with the drug reversing the prolonged muscle ...

DelveInsight's 'Myotonic Dystrophy Pipeline Insight 2024' report provides comprehensive global coverage of pipeline myotonic dystrophy therapies in various stages of clinical development, major ...

Learn about the types and causes of myotonic dystrophy. ... These mutations affect the muscle structure, leading to weakness and altered muscle tone. DM1. ... Genetics; How we reviewed this article: ...

Myotonic muscular dystrophy is the most common type of muscular dystrophy that begins in adulthood. ... “Autosomal” means the gene is located on one of the chromosomes not related to sex.

More than 20 years ago, URMC neurologist Charles Thornton, MD, and others uncovered how a genetic flaw—a “stutter” that results in thousands of repetitions of code on a segment of chromosome ...

Myotonic dystrophy is one of the most common forms of muscular dystrophy. People with the disease have muscle weakness and prolonged muscle tensing (myotonia), making it difficult to relax muscles ...